Sign in

NCT06333236Completed

Effect of Kron (Citicoline and Nicotinamide Oral Solution) on Patients With Open-angle Glaucoma

Source: ClinicalTrials.gov · Last updated 22 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Aim of this study is to investigate the administration effects of the combination of citicoline 40mg/ml and nicotinamide 15mg/ml oral solution (Kron®) on short term improvement in inner retinal function, bioelectrical activity of the visual cortex and visual function.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
1 Feb 2024
Start date
10 Apr 2025
Primary completion date
15 Jul 2025
Lead sponsor
ASST Santi Paolo e Carlo
Diseases
Glaucoma
NCT number
NCT06333236

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 10 Apr 2025 to the primary completion date, 15 Jul 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • ophthalmic surgery 6 months before the recruitment
  • treatment with supplements in any form with a demonstrated or presumed neuroprotecting/neuroenhancing effect in the last six months

Other illness

  • presence of cataract or other conditions that could affect results of perimetry or electroretinography
  • presence of other ocular or systemic diseases that could affect results of perimetry or electroretinography.

Other

  • angle closure glaucoma and secondary open angle glaucoma
  • refractive error outside +2D and -6D

Who the study is looking for

  • glaucomatous patients with moderate visual field loss, MD ranging from -6 dB and -12 dB, and risk of progression
  • controlled intraocular pressure
  • at least 3 previous visual field examinations.

Age in the registry: 40 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Luca Rossetti
Coordinator of this site? Confirm its status
MilanItalyUnknown status
Asst Santi Paolo E Carlo
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.